|
|
Time to Remove the ShacklesThe critically important time-to-market of a drug is often slowed by poor decision-making infrastructures. Being well-informed and looking beyond the realms of R&D to other functional areas can play a major role in bringing a drug to market quickly.
Pharmaceutical companies have long recognized time-to-market as a critical marker for success in the industry. Initiatives have focused on accelerating preclinical and clinical development processes while still ensuring scrupulous science and regulatory compliance. Despite all the attention, however, the results to date have been mixed. Like modern-day Gullivers, pharma managers find themselves tied down by all sorts of restrictions, a lot of them self-imposed.
|